What is a "food-derived bioactive technology" and a "functional food"?
It is becoming increasingly accepted by the scientific community that there are links between specific food groups and their capacity to help reduce the risk of certain diseases. For example, some compounds specifically found in broccoli have been shown to reduce the risk of some cancers. Consuming the actual food may be insufficient to maximise the health benefit due to a number of factors including: the quantity of the food that would need to be consumed; the frequency with which it would need to be consumed; and the way in which the food is prepared prior to consumption.

These health-promoting compounds can be extracted from the food source (called a food-derived bioactive technology) and reintroduced into consumer-friendly lifestyle products which are proven to maintain health (a functional food). Therefore, instead of eating four large servings of broccoli per week, the same benefit may be technically delivered via a 250ml orange juice drink containing the bioactive if consumed once per week.

How is Provexis differentiated from other companies in the market?
Provexis is an evidence-based business which means that we only develop food-derived bioactive technologies and functional food products that have been scientifically proven to deliver a health benefit. This is a different approach from those that promote functional food products in a more generic way with less scientific evidence. We believe that functional food products with strong scientific proof carrying health claims and endorsements will endure and prosper as this rapidly growing market matures.

Provexis is also differentiated with regard to our speed-to-market credentials and the fact that we can create shareholder value via a combination of technology licensing and own brand development.

What food-derived bioactive technologies are being developed by Provexis?
Provexis has developed Fruitflow, a patented extract from tomato that has been proven to inhibit blood platelet aggregation, thereby reducing the risk of thrombosis. A thrombosis is an aberrant blood clot that can lead to heart attack and stroke. Provexis has integrated Fruitflow into a fruit juice beverage called Sirco. When launched - initially in the United Kingdom - it will be the first functional food carrying the claim Helps maintain a healthy heart and benefit circulation with a measurable benefit within hours of consumption.

Provexis is developing a proprietary extract from a special breed of broccoli (non-GMO) which is enriched in compounds known to reduce the risk of specific cancers. Provexis intends to use this food-derived bioactive to underpin a new range of functional beverages with scientifically proven protective properties.

In addition, Provexis is developing a patented extract from plantain with a view to developing a novel medical food for the dietary management of Inflammatory Bowel Disease, specifically Crohns Disease in the first instance.

Now doubled my shares had some that i bought at 12p,sold the rest for a small profit before the drop.Very good news today.

ah bollox!! i knew this would happen once i was out.

Provexis PLC
31 July 2006


PROVEXIS PLC
('Provexis')

Sirco Distribution Gains


Provexis, the nutraceutical company that develops scientifically-proven
functional and medical foods, announces that it has extended the distribution of
its Sirco(TM) heart health juice drink, securing 235 Morrisons outlets with
effect from 14 August 2006.

Sirco(TM) contains the patented Fruitflow(TM) bioactive food ingredient that
reduces blood platelet aggregation, a significant contributing factor to
thrombosis, which can cause heart attack or stroke.

Sirco(TM) is currently distributed in approximately 640 Tesco and Waitrose
supermarkets, and also in 150 Holland & Barratt health food stores, as well as a
number of independent health food wholesalers.

Commenting on the new distribution, Stephen Moon, CEO of Provexis said:

'Securing this important retailer sees us continue to extend distribution of our
patented, scientifically-proven Sirco(TM) product in line with our business
plan.'

Time to take notice of PXS and those patient investors who have continued to have faith in the product development.

Unnamed collaboration of last six months or so is today announced as Unilever.

are you still in Bosley?